These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 13229977)

  • 1. [On partial functional disorders associated with liver disease].
    GEORGI F
    Bibl Paediatr; 1954; 58():675-84. PubMed ID: 13229977
    [No Abstract]   [Full Text] [Related]  

  • 2. The physiologic response of schizophrenic and other psychotic patients to a standard emotional stress.
    PERRIN GM; ALTSCHULE MD
    N Engl J Med; 1957 Apr; 256(15):682-8. PubMed ID: 13451919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biological determination of the toxicity of pathologic body fluids. I. Tests with body fluids of mental and neurological patients].
    RIEDER HP
    Confin Neurol; 1954; 14(2-3):65-87. PubMed ID: 13190852
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver function disorder in multiple sclerosis].
    KRIVANEC E
    Wien Arch Psychol Psychiatr Neurologie; 1954 Dec; 4(4):218-25. PubMed ID: 14374408
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some data on the functional state of the liver in multiple sclerosis].
    AKSIANTSEV MA; VLASOVA PI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():1464-6. PubMed ID: 13681957
    [No Abstract]   [Full Text] [Related]  

  • 6. Obsessive-compulsive disorder in bipolar disorder patients with first manic episode.
    Pashinian A; Faragian S; Levi A; Yeghiyan M; Gasparyan K; Weizman R; Weizman A; Fuchs C; Poyurovsky M
    J Affect Disord; 2006 Aug; 94(1-3):151-6. PubMed ID: 16753221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample.
    Pae CU; Yu HS; Amann D; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH; Patkar AA; Lerer B
    J Psychiatr Res; 2008 Jan; 42(1):35-40. PubMed ID: 17097106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.
    Green MF
    J Clin Psychiatry; 2006 Oct; 67(10):e12. PubMed ID: 17107235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease--there is no schizoaffective disorder.
    Lake CR; Hurwitz N
    Curr Opin Psychiatry; 2007 Jul; 20(4):365-79. PubMed ID: 17551352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.
    Green MF
    J Clin Psychiatry; 2006; 67 Suppl 9():3-8; discussion 36-42. PubMed ID: 16965182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Barcelona Bipolar Eating Disorder Scale for bipolar patients with eating disturbances.
    Torrent C; Vieta E; Garcia-Garcia M;
    Psychopathology; 2008; 41(6):379-87. PubMed ID: 18787360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of axis I antecedents before age 18 of unipolar depression, bipolar disorder and schizophrenia.
    Rubino IA; Frank E; Croce Nanni R; Pozzi D; Lanza di Scalea T; Siracusano A
    Psychopathology; 2009; 42(5):325-32. PubMed ID: 19672135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Dickerson F; Boronow JJ; Stallings C; Origoni AE; Cole SK; Yolken RH
    Psychiatry Res; 2004 Nov; 129(1):45-53. PubMed ID: 15572184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for shared susceptibility in bipolar disorder and schizophrenia.
    Berrettini W
    Am J Med Genet C Semin Med Genet; 2003 Nov; 123C(1):59-64. PubMed ID: 14601037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis.
    Glahn DC; Bearden CE; Cakir S; Barrett JA; Najt P; Serap Monkul E; Maples N; Velligan DI; Soares JC
    Bipolar Disord; 2006 Apr; 8(2):117-23. PubMed ID: 16542181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
    Tian SY; Wang JF; Bezchlibnyk YB; Young LT
    Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the problem of disorders of sensitivity in multiple sclerosis].
    BABENKOVA SV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():1444-52. PubMed ID: 13685535
    [No Abstract]   [Full Text] [Related]  

  • 19. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies.
    Kim H; McGrath BM; Silverstone PH
    Hum Psychopharmacol; 2005 Jul; 20(5):309-26. PubMed ID: 15880397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.